Cell Source Stock

Cell Source EBIT per Share

The EBIT per Share of Cell Source (CLCS) as of Sep 4, 2026 is -0.11 USD. In the previous year, EBIT per Share was -0.12 USD — a change of -7.74% (higher).

EBIT per Share

-0.11USD

YoY

-7.74%

Last updated:

EBIT per Share of Cell Source is 2026 -0.11 USD. EBIT per Share of Cell Source was 2025 -0.12 USD. It decreases by -7.74% higher compared to the previous year.

The Cell Source EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2016
-0.09 USD
Jan 1, 2017
-0.09 USD
Jan 1, 2018
-0.07 USD
Jan 1, 2019
-0.13 USD
Jan 1, 2020
-0.13 USD
Jan 1, 2021
-0.12 USD
Jan 1, 2022
-0.12 USD
Jan 1, 2023
-0.11 USD
The Cell Source EBIT per Share history
YEAREBIT per ShareYoY
-0.11USD-7.74%
-0.12USD-1.15%
-0.12USD-2.97%
-0.13USD-6.75%
-0.13USD+84.77%
-0.07USD-15.51%
-0.09USD-3.01%
-0.09USD-1.79%
-0.09USD-50.58%
-0.18USD+254.28%
-0.05USD-12.57%
-0.06USD
Access this data via the Eulerpool API

Cell Source Stock analysis

What does Cell Source do? Cell Source is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cell Source stock

EBIT per Share of Cell Source is -0.11 USD in 2026.

EBIT per Share of Cell Source changed from -0.12 USD to -0.11 USD, representing a -7.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Cell Source since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

Income Statement — Cell Source

All Key Metrics — Cell Source